 Connection
Stephen Waldo to Veterans Health
This is a "connection" page, showing publications Stephen Waldo has written about Veterans Health.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.390 |
|
|
|
-
Kovach CP, Lipinski J, Mesenbring EC, Boulos P, Pribish A, Sola M, Glorioso TJ, Fearon WF, Yeh RW, Waldo SW. Characteristics and Outcomes of PCI Among Patients Ineligible for Surgical Revascularization in the Veterans Affairs Healthcare System. Circ Cardiovasc Interv. 2025 Mar; 18(3):e014899.
Score: 0.833
-
Bricker RS, Glorioso TJ, Jawaid O, Plomondon ME, Valle JA, Armstrong EJ, Waldo SW. Temporal Trends and Site Variation in High-Risk Coronary Intervention and the Use of Mechanical Circulatory Support: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2019 12 17; 8(24):e014906.
Score: 0.578
-
Prouse AF, Langner P, Plomondon ME, Ho PM, Valle JA, Bar?n AE, Armstrong EJ, Waldo SW. Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population. Vasc Med. 2019 02; 24(1):41-49.
Score: 0.527
-
Valle JA, Glorioso TJ, Bricker R, Bar?n AE, Armstrong EJ, Bhatt DL, Rao SV, Plomondon ME, Serruys PW, Keppetein AP, Sabik JF, Dressler O, Stone GW, Waldo SW. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program. JAMA Cardiol. 2019 08 01; 4(8):727-735.
Score: 0.141
-
Valle JA, Josey K, Prouse AF, Zimmet J, Waldo SW. Dual antiplatelet therapy in non-ST elevation acute coronary syndromes at Veterans Affairs Hospitals. Heart. 2019 10; 105(20):1575-1582.
Score: 0.139
-
Valle JA, Schofield RS, Waldo SW. Ensuring Optimal Adjustment for Determinations of Institutional Quality. JAMA Cardiol. 2018 11 01; 3(11):1129-1130.
Score: 0.134
-
Salahuddin T, Richardson V, McNeal DM, Henderson K, Hess PL, Raghavan S, Saxon DR, Valle JA, Waldo SW, Ho PM, Schwartz GG. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab. 2021 01; 23(1):97-105.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|